47 results on '"Mallidi, H.R."'
Search Results
2. Heart and Combined Heart–Kidney Transplantation in Patients With Concomitant Renal Insufficiency and End-Stage Heart Failure
3. Fatal Cardiac and Renal Allograft Rejection With Lenalidomide Therapy for Light-Chain Amyloidosis
4. The Impact of Left Ventricular Assist Device Infections on Clinical Outcomes
5. Antibody Responses to COVID-19 Vaccination in Left Ventricular Assist Devices
6. Factors Associated with Very Long-Term Survival for Lung Transplant Recipients
7. Long-Term Outcomes in Heart and Lung Transplants from HCV-Viremic Donors to Uninfected Recipients: The Donate HCV Trial
8. Twenty-Year Survivors of Heart Transplantation at Stanford University
9. The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems
10. A Contemporary Analysis of the Safety and Efficacy of Cardiac Transplantation from Donors with Blood Infections
11. Utility of Comprehensive Assessment for Hepatic Fibrosis in Lung Transplant Candidates
12. Short Term Outcomes After Lung Transplantation: Sternotomy Offers Advantages Over Clamshell Approach
13. Transplanting Thoracic Organs from Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients
14. Early Results of Biventricular Support with Durable, Intracorporeal Continuous Flow Centrifugal Ventricular Assist Devices: Analysis from INTERMACS
15. Investigating a Novel Synergy Applying Remote I schemic Conditioning to M odulate the Altered P hysiology of Contin U ous Flow L eft Ventricular Assist Devices, to Reduce S troke and Other Adverse E ffects: The IMPULSE Trial Pilot Results
16. (1173) - Short Term Outcomes After Lung Transplantation: Sternotomy Offers Advantages Over Clamshell Approach
17. (340) - Transplanting Thoracic Organs from Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients
18. Predictors of Late Survival Following Continuous-Flow Left Ventricular Assist Devices
19. Early and Mid-Term Predicted Survival in Transplant Eligible Elderly Patients Is Superior With Transplant Versus Left Ventricular Assist Device Bridge-to-Transplant Therapy
20. Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use
21. Enhanced Donor Organ Quality Assurance Using Novel Point-of-View Video Streaming Technology During Harvesting
22. Ventricular Reconditioning Enables De-Escalation of Therapy in Young Patients Supported By Continuous Flow Left Ventricular Assist Devices
23. Response to Letter Regarding Article Entitled “Heart and Combined Heart–Kidney Transplantation in Patients With Concomitant Renal Insufficiency and End-Stage Heart Failure”
24. Patterns of Readmission With Contemporary Continuous Flow Circulatory Support
25. The Role of Ventricular Reconditioning in Weaning From Continuous-Flow Ventricular Assist Devices
26. First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use
27. Mid and Late Outcomes Support Use of Contemporary Continuous Flow Left Ventricular Assist Devices in the Elderly
28. Right Ventricular Assist Device Support After Continuous Flow Left Ventricular Assist Device Implantation: Predicting a Poor Predictor
29. 165 Analysis of over 1000 Patients Listed for Combined Heart-Kidney Transplant in the Modern Era
30. 49 Five Years of Lung Transplantation Since the Implementation of the Lung Allocation Score: A Comparative Analysis of Patient Characteristics and Outcomes
31. 128 Redo Sternotomy in Patients Undergoing Heart Transplantation: A Propensity-Matched Survival Analysis of the United Network for Organ Sharing Database
32. Early Outcomes of Deliberate Nonoperative Management for Blunt Thoracic Aortic Injury in Trauma
33. 61 The Association between Poor Socioeconomic Status and Poor Long-Term Outcomes Following Heart Transplantation
34. (671) - Enhanced Donor Organ Quality Assurance Using Novel Point-of-View Video Streaming Technology During Harvesting
35. (519) - Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use
36. (490) - Early and Mid-Term Predicted Survival in Transplant Eligible Elderly Patients Is Superior With Transplant Versus Left Ventricular Assist Device Bridge-to-Transplant Therapy
37. (88) - Ventricular Reconditioning Enables De-Escalation of Therapy in Young Patients Supported By Continuous Flow Left Ventricular Assist Devices
38. (44) - Predictors of Late Survival Following Continuous-Flow Left Ventricular Assist Devices
39. 12: ABO Minor Mismatch in Lung Transplantation – An Analysis of the UNOS Database
40. 256: Pacemaker Use Following Heart Transplantation
41. (641) - Right Ventricular Assist Device Support After Continuous Flow Left Ventricular Assist Device Implantation: Predicting a Poor Predictor
42. (565) - Mid and Late Outcomes Support Use of Contemporary Continuous Flow Left Ventricular Assist Devices in the Elderly
43. (549) - The Role of Ventricular Reconditioning in Weaning From Continuous-Flow Ventricular Assist Devices
44. (535) - Patterns of Readmission With Contemporary Continuous Flow Circulatory Support
45. (79) - First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use
46. (1103) - Investigating a Novel Synergy Applying Remote Ischemic Conditioning to Modulate the Altered Physiology of ContinUous Flow Left Ventricular Assist Devices, to Reduce Stroke and Other Adverse Effects: The IMPULSE Trial Pilot Results.
47. (236) - Early Results of Biventricular Support with Durable, Intracorporeal Continuous Flow Centrifugal Ventricular Assist Devices: Analysis from INTERMACS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.